Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The clinical progression of Parkinson's disease.
Poewe W, Mahlknecht P. Poewe W, et al. Among authors: mahlknecht p. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S28-32. doi: 10.1016/S1353-8020(09)70831-4. Parkinsonism Relat Disord. 2009. PMID: 20123553 Review.
Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons.
Berg D, Seppi K, Behnke S, Liepelt I, Schweitzer K, Stockner H, Wollenweber F, Gaenslen A, Mahlknecht P, Spiegel J, Godau J, Huber H, Srulijes K, Kiechl S, Bentele M, Gasperi A, Schubert T, Hiry T, Probst M, Schneider V, Klenk J, Sawires M, Willeit J, Maetzler W, Fassbender K, Gasser T, Poewe W. Berg D, et al. Among authors: mahlknecht p. Arch Neurol. 2011 Jul;68(7):932-7. doi: 10.1001/archneurol.2011.141. Arch Neurol. 2011. PMID: 21747034
A follow-up study of substantia nigra echogenicity in healthy adults.
Mahlknecht P, Stockner H, Nocker M, Kiechl S, Willeit J, Scherfler C, Sojer M, Gasperi A, Rungger G, Poewe W, Seppi K. Mahlknecht P, et al. Mov Disord. 2012 Aug;27(9):1196-7. doi: 10.1002/mds.25080. Epub 2012 Jun 14. Mov Disord. 2012. PMID: 22700445 No abstract available.
Emerging therapies for Parkinson's disease.
Poewe W, Mahlknecht P, Jankovic J. Poewe W, et al. Among authors: mahlknecht p. Curr Opin Neurol. 2012 Aug;25(4):448-59. doi: 10.1097/WCO.0b013e3283542fde. Curr Opin Neurol. 2012. PMID: 22772874 Review.
The PRIPS study: screening battery for subjects at risk for Parkinson's disease.
Berg D, Godau J, Seppi K, Behnke S, Liepelt-Scarfone I, Lerche S, Stockner H, Gaenslen A, Mahlknecht P, Huber H, Srulijes K, Klenk J, Fassbender K, Maetzler W, Poewe W; PRIPS study group. Berg D, et al. Among authors: mahlknecht p. Eur J Neurol. 2013 Jan;20(1):102-8. doi: 10.1111/j.1468-1331.2012.03798.x. Epub 2012 Aug 1. Eur J Neurol. 2013. PMID: 22852790
Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.
Berg D, Behnke S, Seppi K, Godau J, Lerche S, Mahlknecht P, Liepelt-Scarfone I, Pausch C, Schneider N, Gaenslen A, Brockmann K, Srulijes K, Huber H, Wurster I, Stockner H, Kiechl S, Willeit J, Gasperi A, Fassbender K, Gasser T, Poewe W. Berg D, et al. Among authors: mahlknecht p. Mov Disord. 2013 Feb;28(2):216-9. doi: 10.1002/mds.25192. Epub 2012 Oct 31. Mov Disord. 2013. PMID: 23115051
104 results